首页 | 本学科首页   官方微博 | 高级检索  
检索        

夜香树甾体皂苷抑制人肝癌裸鼠移植瘤的研究
引用本文:农智新,赵世元,张明艳,黄之虎,叶海洪,钟振国,李彩萍.夜香树甾体皂苷抑制人肝癌裸鼠移植瘤的研究[J].中国实验方剂学杂志,2013,19(17):239-243.
作者姓名:农智新  赵世元  张明艳  黄之虎  叶海洪  钟振国  李彩萍
作者单位:广西壮族自治区民族医院, 南宁 530001;广西壮族自治区民族医院, 南宁 530001;广西中医药大学, 南宁 530001;广西壮族自治区民族医院, 南宁 530001;广西壮族自治区民族医院, 南宁 530001;广西中医药大学, 南宁 530001;广西中医药大学, 南宁 530001
基金项目:广西科技攻关项目(桂科攻0816004-17);广西医疗卫生科研课题(Z2008029)
摘    要:目的: 观察夜香树甾体皂苷(SSCN)对HepG2肝癌移植瘤的抑制作用,并探讨其抑瘤的可能机制。方法: 从夜香树叶和嫩枝用有机溶剂提取、分离并鉴定SSCN。应用人肝癌细胞株HepG2皮下接种法建立移植瘤模型,建模成功后将荷人肝癌裸鼠随机分为5组:生理盐水组0.2 mL·次-1、沙利度胺(TLD)组200 mg·kg-1和SSCN低,中,高剂量组4,6,8 mg·kg-1。隔天ip给药,在治疗期间测量皮下移植瘤的长径和短径;30 d后处死裸鼠,免疫组化法检测移植瘤中微血管密度(MVD)和血管内皮细胞生长因子(VEGF)的表达,用酶联免疫法(ELISA)法检测裸鼠血清中白细胞介素-8(IL-8)的表达。结果: SSCN低,中,高剂量ip给药对肝癌裸鼠移植瘤相对肿瘤细胞增殖率分别为对照组(100%)的48.26%,42.94%,41.57%,TLD组的相对肿瘤增殖率为42.19%。SSCN各组及TLD组的MVD,VEGF和IL-8的水平都明显低于模型组(P<0.01)。结论: 夜香树叶甾体皂苷体内对BALB/c裸鼠肝癌移植瘤有一定的抑制作用,其作用机制可能通过抑制VEGF,MVD的表达以及IL-8的转录,导致肿瘤血管生成受到抑制。

关 键 词:夜香树甾体皂苷  肝癌细胞HepG2  微血管密度  血管内皮生长因子  白细胞介素-8
收稿时间:2012/12/6 0:00:00

Antitumor Effects of Steroidal Saponins of Cestrum nocturnum (SSCN) on Human Hepatocellular Carcinoma Xenografts in Nude Mice
NONG Zhi-xin,ZHAO Shi-yuan,ZHANG Ming-yan,HUANG Zhi-hu,YE Hai-hong,ZHONG Zhen-guo and LI Cai-ping.Antitumor Effects of Steroidal Saponins of Cestrum nocturnum (SSCN) on Human Hepatocellular Carcinoma Xenografts in Nude Mice[J].China Journal of Experimental Traditional Medical Formulae,2013,19(17):239-243.
Authors:NONG Zhi-xin  ZHAO Shi-yuan  ZHANG Ming-yan  HUANG Zhi-hu  YE Hai-hong  ZHONG Zhen-guo and LI Cai-ping
Institution:Guangxi National Hospital, Nanning 530001, China;Guangxi National Hospital, Nanning 530001, China;Guangxi University of Chinese Medicine, Nanning 530001, China;Guangxi National Hospital, Nanning 530001, China;Guangxi National Hospital, Nanning 530001, China;Guangxi University of Chinese Medicine, Nanning 530001, China;Guangxi University of Chinese Medicine, Nanning 530001, China
Abstract:Objective: To investigate the antitumor effects and mechanism of steroidal saponins of Cestrum nocturnum(SSCN) on human hepatocellular carcinoma xenografts in nude mice in vivo. Method: SSCN from the leaves and twigs of cestrum nocturnum,Linn were separated and their structures were identified by solvent;the animal model of human hepatocellular carcinoma xenografts was constructed by subcutaneous inoculation of hepatocellular carcinoma HepG2 cells into nude mice.The mice were randomly divided into five groups:NS group(0.2 mL),thalidomide(TLD) group(200 mg·kg-1),and SSCN low,medium and high dose groups(4,6,8 mg·kg-1).During treatment,tumor size was measured.The mice were killed 30 days later to observe tumor morphology.The angiogenesis was assessed by immunohistochemical staining using anti-vascular endothelia grouth factor(VEGF) and cluster of differentiation 34(CD34) antibodies,the expression of interleukin-8(IL-8) of serum was detected by ELISA. Result: The relative proliferation rate in experimental groups (low,medium and high doses) was 48.26%,42.94% and 41.57%,respectively,and in positive group (thalidomide) the relative proliferation rate was 42.19%. Compared with the NS group, the expression of MVD, VEGF and IL-8 were was markedly lowered in all SSCN treatment groups and TLD group (P<0.01). Conclusion: SSCN has a certain inhibitory effect on tumor nude mice in vivo. The anti-tumor mechanism is probably related to the inhibition of activity of VEGF, MVD and IL-8, and downregulating the expression of proangiogenic factors.
Keywords:steroidal saponins of Cestrum nocturnum (SSCN)  human hepatocellular carcinoma cell line HepG2  MVD  VEGF  IL-8
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号